Want to see SIGY full AI Analyst Report?
Sigyn Therapeutics (SIGY) Financial Statements
Sigyn Therapeutics Financial Overview
Sigyn Therapeutics's market cap is currently $147.84K. The company's EPS TTM is $-2.09; its P/E ratio is -0.01; Sigyn Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.36K | $ -5.61K | $ -8.86K | $ -10.45K | ― |
| Operating Income | $ -1.79M | $ -2.52M | $ -2.46M | $ -2.15M | $ -2.01M |
| EBITDA | $ -1.78M | $ -3.33M | $ -2.45M | $ -2.14M | $ -2.53M |
| Net Income | $ -3.36M | $ -3.34M | $ -4.15M | $ -3.71M | $ -3.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 20.33K | $ 12.14K | $ 11.69K | $ 8.36K | $ 340.96K |
| Total Assets | $ 107.52K | $ 213.72K | $ 321.81K | $ 332.88K | $ 710.26K |
| Total Debt | $ 3.06M | $ 2.19M | $ 2.40M | $ 1.88M | $ 980.01K |
| Net Debt | $ 3.04M | $ 2.18M | $ 2.39M | $ 1.87M | $ 639.05K |
| Total Liabilities | $ 6.55M | $ 4.67M | $ 3.73M | $ 2.24M | $ 974.84K |
| Stockholders' Equity | $ -6.44M | $ -4.46M | $ -3.41M | $ -1.90M | $ -264.58K |
| Cash Flow | |||||
| Free Cash Flow | $ -852.28K | $ -872.44K | $ -1.38M | $ -1.83M | $ -1.80M |
| Operating Cash Flow | $ -852.27K | $ -872.44K | $ -1.38M | $ -1.83M | $ -1.77M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ -860.00 | $ -29.26K |
| Financing Cash Flow | $ 860.46K | $ 872.89K | $ 1.39M | $ 1.50M | $ 2.06M |
Currency in USD
